Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 30Observational 1

Sponsor

Cancer Type

Thoracic 137Gastrointestinal 29Genitourinary 19Breast 18Head & Neck 16Gynecologic 15Dermatologic 9CNS 8Other solid neoplasm 7Sarcoma 4Other neoplasm 3Endocrine 3Plasma cell 2Other hematologic neoplasm 2Other 1NET 1Lymphoid 1

Conditions

Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Leukemia, Lymphocytic, Chronic, B-Cell 215Lymphoma, Non-Hodgkin 204Lymphoma, Follicular 193Lymphoma, Large B-Cell, Diffuse 180Leukemia 164Hodgkin Disease 160Multiple Myeloma 118Neoplasms 97Leukemia, Myeloid, Acute 87Lymphoma, Mantle-Cell 78Burkitt Lymphoma 67Myelodysplastic Syndromes 64Lymphoma, B-Cell, Marginal Zone 64Lymphoma, T-Cell, Cutaneous 62Breast Neoplasms 62Mycosis Fungoides 55Recurrence 52Lymphoma, B-Cell 50Hematologic Neoplasms 50Sezary Syndrome 43Waldenstrom Macroglobulinemia 41Myeloproliferative Disorders 39Neoplasms, Plasma Cell 38Lung Neoplasms 34Lymphoma, Large-Cell, Immunoblastic 33Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 32Lymphoma, T-Cell, Peripheral 29Leukemia, Hairy Cell 29

Interventions

Carboxylesterase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Small Cell Lung Carcinoma × Lymphoid × Clear all
NCT04106167 2023-09-21

Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

Fate Therapeutics

Terminated
20 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Melanoma, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Microsatellite Instability, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡